FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.1444.3.214

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113883.3.1444.3.214
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.214/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.214
Version20230411
Statusactive
Date2023-04-11T01:00:57-04:00
NameBRAFV600Testing
TitleBRAF V600 Testing
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this value set is to represent concepts for the procedure of BRAF V600 testing.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for BRAF V600 testing.),(Exclusion Criteria: No exclusions.)

Resources that use this resource

ValueSet
2.16.840.1.113883.3.1444.5.239BRAF V600 Testing

Resources that this resource uses

CodeSystem
cptCurrent Procedural Terminology (CPT®)

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.1444.3.214",
  "meta": {
    "versionId": "11",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "American Society of Clinical Oncology Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-07-03"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2023-04-11"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.214",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.1444.3.214"
    }
  ],
  "version": "20230411",
  "name": "BRAFV600Testing",
  "title": "BRAF V600 Testing",
  "status": "active",
  "date": "2023-04-11T01:00:57-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for the procedure of BRAF V600 testing.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for BRAF V600 testing.),(Exclusion Criteria: No exclusions.)",
  "compose": {
    "include": [
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "concept": [
          {
            "code": "81210",
            "display": "BRAF (B-Raf proto-oncogene, serine/threonine kinase) (eg, colon cancer, melanoma), gene analysis, V600 variant(s)"
          },
          {
            "code": "81455",
            "display": "Targeted genomic sequence analysis panel, solid organ or hematolymphoid neoplasm or disorder, 51 or greater genes (eg, ALK, BRAF, CDKN2A, CEBPA, DNMT3A, EGFR, ERBB2, EZH2, FLT3, IDH1, IDH2, JAK2, KIT, KRAS, MET, MLL, NOTCH1, NPM1, NRAS, PDGFRA, PDGFRB, PGR, PIK3CA, PTEN, RET), interrogation for sequence variants and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed; DNA analysis or combined DNA and RNA analysis"
          },
          {
            "code": "81479",
            "display": "Unlisted molecular pathology procedure"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:c0a60b5c-d590-445d-9c1e-3ddd8018fd29",
    "timestamp": "2025-05-23T21:55:00-04:00",
    "total": 3,
    "contains": [
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "81210",
        "display": "BRAF (B-Raf proto-oncogene, serine/threonine kinase) (eg, colon cancer, melanoma), gene analysis, V600 variant(s)"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "81455",
        "display": "Solid organ or hematolymphoid neoplasm or disorder, 51 or greater genes, genomic sequence analysis panel, interrogation for sequence variants and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed; DNA analysis or combined DNA and RNA analysis"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "81479",
        "display": "Unlisted molecular pathology procedure"
      }
    ]
  }
}